My Companies
Notification
Account
Log Out
Login
On September 7, 2026, Novartis India approved and signed agreements to acquire Minipress and Minipres trademarks and related Indian intellectual property from Pfizer for ₹1,250 crore. Minipress XL generated ₹228.6 crore revenue and grew 6.3% CAGR, making this a transformative acquisition.